Special Issue "New Possibilities for the Treatment of Dyslipidemias"
Deadline for manuscript submissions: closed (15 July 2023) | Viewed by 849
There is a broad spectrum of new developments concerning possibilities for treatment of dyslipidemias, particularly in the last several years. The aim of this Special Issue is to try to focus on those substances that have a chance to be implemented in clinical practice as well as some dietary approaches and nutraceuticals that might be beneficial in treating dyslipidemias and preventing atherosclerotic cardiovascular disease. Particularly interesting are the available data concerning the possible adverse effects of new substances that are proposed as novel treatment possibilities for dyslipidemias. New biomarkers might also be helpful in making decisions about dyslipidemia treatment, but they require solid and proven data for their clinical use. The articles in this Special Issue are intended to help to implement novel methods for everyday clinical approaches to diagnostics and treatment of different dyslipidemias in order to prevent atherosclerotic cardiovascular disease, which is the killer number one not only in developed countries, as it used to be, but around the world.
Prof. Dr. Zeljko Reiner
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- atherosclerotic cardiovascular disease
- diagnostics and treatment